Focus areas: Establish hydration habits now, before higher doses make GI symptoms more pronounced Track protein intake for at least one week to establish a baseline Begin or maintain light exercise (walking 20 to 30 minutes daily) Get bloodwork done if you do not have recent results (ferritin, B12, vitamin D, metabolic panel) Start an electrolyte supplement if experiencing any nausea or GI symptoms The goal at this stage is building habits that will protect you at higher doses
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells
Studies have also suggests that it may help alleviate some of the complications associated with diabetes, such as nerve damage and kidney disease
Its important to have an open conversation with your provider about the potential pros and cons of microdosing
Not all GLP-1s are approved for obesity treatment, and this analysis includes all FDA-approved GLP-1s, including those approved for obesity (Saxenda, Weogvy, Zepbound) as well as those approved for type 2 diabetes (see Table 1)
Research also suggests potential involvement in regulating cytokines such as IL-6 and pathways such as NF-B and MAPK